Your Expert Partner For Efficient Drug Discovery

OriBase Pharma is an international contract research organization (CRO) specialized in the design and chemistry synthesis of kinase inhibitors, and dedicated to accelerating drug discovery processes.

Our mission is to deliver safe, drug-like novel molecular entities for clients’ projects through the application of a unique technology platform & efficient discovery processes. Our commitment is to accomplish this with the highest quality & speed.

Our technologies are based on a unique combination of rational in silico drug design & medicinal chemistry services.

Value Creation for Our Clients

Synthetically feasible, patentable & PK/toxicology profiled lead series
within 18-24 months cycle time, including 2-3 iterations
Current success: 10-20% hit-ratein 4 projects
IP created belongs to the client
Valuable ROI for our clients

OriBase Pharma is involved in all drug discovery stages from hit identification to lead optimization and delivery of new drug candidates in a quick and cost effective manner. OriBase Pharma has worked on a wide range of therapeutic target classes and has a specific expertise in kinase inhibitors design. With our innovative approach and proprietary platform, we successfully design and develop new drug candidates, particularly for cancer and autoimmune diseases.

Share |